Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
Clinical trial NCT03048474 · COMPLETED
Trial details
- NCT number
- NCT03048474
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.